FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3130466842> ?p ?o ?g. }

• W3130466842 abstract "Chronic kidney disease (CKD) has been recognized as a leading public health problem worldwide. Through its effect on cardiovascular risk and end-stage kidney disease, CKD directly affects the global burden of morbidity and mortality. Classical optimal management of CKD includes blood pressure control, treatment of albuminuria with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, avoidance of potential nephrotoxins and obesity, drug dosing adjustments, and cardiovascular risk reduction. Diabetes might account for more than half of CKD burden, and obesity is the most important prompted factor for this disease. New antihyperglycemic drugs, such as sodium-glucose-cotransporter 2 inhibitors have shown to slow the decline of GFR, bringing additional benefit in weight reduction, cardiovascular, and other kidney outcomes. On the other hand, a new generation of non-steroidal mineralocorticoid receptor antagonist has recently been developed to obtain a selective receptor inhibition reducing side effects like hyperkalemia and thereby making the drugs suitable for administration to CKD patients. Moreover, two new potassium-lowering therapies have shown to improve tolerance, allowing for higher dosage of renin-angiotensin system inhibitors and therefore enhancing their nephroprotective effect. Regardless of its cause, CKD is characterized by reduced renal regeneration capacity, microvascular damage, oxidative stress and inflammation, resulting in fibrosis and progressive, and irreversible nephron loss. Therefore, a holistic approach should be taken targeting the diverse processes and biological contexts that are associated with CKD progression. To date, therapeutic interventions when tubulointerstitial fibrosis is already established have proved to be insufficient, thus research effort should focus on unraveling early disease mechanisms. An array of novel therapeutic approaches targeting epigenetic regulators are now undergoing phase II or phase III trials and might provide a simultaneous regulatory activity that coordinately regulate different aspects of CKD progression." @default.
• W3130466842 created "2021-03-01" @default.
• W3130466842 creator A5048784225 @default.
• W3130466842 creator A5061098649 @default.
• W3130466842 creator A5070978722 @default.
• W3130466842 date "2021-02-23" @default.
• W3130466842 modified "2023-10-15" @default.
• W3130466842 title "Therapeutic Insights in Chronic Kidney Disease Progression" @default.
• W3130466842 cites W1607356529 @default.
• W3130466842 cites W1967774089 @default.
• W3130466842 cites W1981055539 @default.
• W3130466842 cites W1984061204 @default.
• W3130466842 cites W1986588593 @default.
• W3130466842 cites W1995380245 @default.
• W3130466842 cites W2010538618 @default.
• W3130466842 cites W2026703386 @default.
• W3130466842 cites W2026719046 @default.
• W3130466842 cites W2034909520 @default.
• W3130466842 cites W2044773944 @default.
• W3130466842 cites W2049230993 @default.
• W3130466842 cites W2056194572 @default.
• W3130466842 cites W2056976690 @default.
• W3130466842 cites W2060437379 @default.
• W3130466842 cites W2063210769 @default.
• W3130466842 cites W2066757269 @default.
• W3130466842 cites W2074219405 @default.
• W3130466842 cites W2076927183 @default.
• W3130466842 cites W2079131261 @default.
• W3130466842 cites W2079169053 @default.
• W3130466842 cites W2087285082 @default.
• W3130466842 cites W2088396203 @default.
• W3130466842 cites W2100169278 @default.
• W3130466842 cites W2108140227 @default.
• W3130466842 cites W2108629029 @default.
• W3130466842 cites W2112948259 @default.
• W3130466842 cites W2118100479 @default.
• W3130466842 cites W2118932957 @default.
• W3130466842 cites W2120235169 @default.
• W3130466842 cites W2124044470 @default.
• W3130466842 cites W2127906346 @default.
• W3130466842 cites W2128451215 @default.
• W3130466842 cites W2129458801 @default.
• W3130466842 cites W2134172788 @default.
• W3130466842 cites W2135120138 @default.
• W3130466842 cites W2138862624 @default.
• W3130466842 cites W2143633302 @default.
• W3130466842 cites W2145632481 @default.
• W3130466842 cites W2152798629 @default.
• W3130466842 cites W2156753852 @default.
• W3130466842 cites W2162368776 @default.
• W3130466842 cites W2164469730 @default.
• W3130466842 cites W2171324990 @default.
• W3130466842 cites W2185616741 @default.
• W3130466842 cites W2195506720 @default.
• W3130466842 cites W2252435576 @default.
• W3130466842 cites W2305862175 @default.
• W3130466842 cites W2424539745 @default.
• W3130466842 cites W2470481127 @default.
• W3130466842 cites W2528385426 @default.
• W3130466842 cites W2592974986 @default.
• W3130466842 cites W2594224602 @default.
• W3130466842 cites W2615684303 @default.
• W3130466842 cites W2626446274 @default.
• W3130466842 cites W2793635522 @default.
• W3130466842 cites W2870743986 @default.
• W3130466842 cites W2895076612 @default.
• W3130466842 cites W2898491544 @default.
• W3130466842 cites W2937955146 @default.
• W3130466842 cites W2939222610 @default.
• W3130466842 cites W2949665037 @default.
• W3130466842 cites W2950546578 @default.
• W3130466842 cites W2972966903 @default.
• W3130466842 cites W2980098671 @default.
• W3130466842 cites W2995632710 @default.
• W3130466842 cites W2996130540 @default.
• W3130466842 cites W2999129752 @default.
• W3130466842 cites W3005957464 @default.
• W3130466842 cites W3006609143 @default.
• W3130466842 cites W3021250193 @default.
• W3130466842 cites W3088173406 @default.
• W3130466842 cites W3092125826 @default.
• W3130466842 cites W3094429645 @default.
• W3130466842 cites W3156148333 @default.
• W3130466842 doi "https://doi.org/10.3389/fmed.2021.645187" @default.
• W3130466842 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7940523" @default.
• W3130466842 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33708784" @default.
• W3130466842 hasPublicationYear "2021" @default.
• W3130466842 type Work @default.
• W3130466842 sameAs 3130466842 @default.
• W3130466842 citedByCount "31" @default.
• W3130466842 countsByYear W31304668422021 @default.
• W3130466842 countsByYear W31304668422022 @default.
• W3130466842 countsByYear W31304668422023 @default.
• W3130466842 crossrefType "journal-article" @default.
• W3130466842 hasAuthorship W3130466842A5048784225 @default.
• W3130466842 hasAuthorship W3130466842A5061098649 @default.
• W3130466842 hasAuthorship W3130466842A5070978722 @default.
• W3130466842 hasBestOaLocation W31304668421 @default.
• W3130466842 hasConcept C126322002 @default.
• W3130466842 hasConcept C134018914 @default.

• next